Results 1 to 10 of about 312,011 (322)

ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19

open access: yesJournal of Clinical and Translational Science, 2023
Despite the availability of vaccinations, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause Coronavirus Disease 2019 (COVID-19) infection with a spectrum of disease in the acute setting.
The Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group
doaj   +1 more source

Perceived Barriers and Intentions to Receive COVID-19 Vaccines: Psychological Distress as a Moderator

open access: yesVaccines, 2023
A high vaccination uptake degree is crucial to achieve herd immunity to COVID-19 and restrict the spread of the COVID-19 pandemic. However, little is known about the antecedents that reduce or contribute to shaping the intention to receive COVID-19 ...
Ngo Thi Viet Nga   +4 more
doaj   +1 more source

Predictive Factors of Mortality in Patients with Severe COVID-19 Treated in the Intensive Care Unit: A Single-Center Study in Vietnam

open access: yesPulmonary Therapy, 2023
Introduction The fourth outbreak of COVID-19 with the delta variant in Vietnam was very fierce due to the limited availability of vaccines and the lack of healthcare resources.
Sy Duong-Quy   +19 more
doaj   +1 more source

Are Vaccines Effective in Preventing Variant COVID 19 Disease? A Case of Vaccinated Variant COVID 19

open access: yesAnkara Medical Journal, 2021
COVID 19 disease caused by the SARS-CoV-2 virus is the most important public health problem of today. The pandemic caused by this virus has radically changed the way of life all over the world. Vaccines developed against this virus are our most important
Bahadır Ertürk   +2 more
doaj   +1 more source

Dermatological Complications of COVID 19 Vaccines: An Updated Review

open access: yesNational Journal of Community Medicine, 2023
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the 2019 coronavirus disease (COVID-19) pandemic, have been rapidly developed and authorized.
Mohammed Omar Alsadi, Vinita John
doaj   +1 more source

SOCIAL REPRESENTATIONS ON VACCINES AND VACCINATION AGAINST COVID 19

open access: yesRevista Científica Arbitrada de la Fundación MenteClara, 2021
The representations are described as a specific style of knowledge, a specific way of deciphering reality, alluding to common sense thinking, being associated with a personal development that involves cognitive ordering and at the same time finds its ...
Valeria Fernanda Altamirano   +20 more
doaj   +1 more source

COVID-19 Booster Vaccines Administration in Different Countries

open access: yesProgress in Microbes and Molecular Biology, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus
Angel Yun-Kuan Thye   +3 more
doaj   +1 more source

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 [PDF]

open access: yes, 2020
Background and purpose Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported.
Boon, Paul   +6 more
core   +2 more sources

How can COVID-19 vaccines benefit people? A study based on the theory of the commons

open access: yesHuman Vaccines & Immunotherapeutics, 2023
COVID−19 vaccination is a fundamental step toward controlling the COVID−19 pandemic and defusing the public health crisis it has caused. Existing studies have demonstrated that equitable distribution of COVID−19 vaccines can only be achieved if these ...
Yiqing Su   +3 more
doaj   +1 more source

The Willingness of Elderly Taiwanese Individuals to Accept COVID-19 Vaccines after the First Local Outbreak

open access: yesVaccines, 2022
Vaccination is the most effective intervention to prevent infection and subsequent complications from SARS-CoV-2. Because of their multiple comorbidities, the elderly population experienced the highest number of deaths from the COVID-19 pandemic ...
Chia-Yu Huang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy